Skip Navigation

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (34)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Manabe, N.
Right arrow Articles by Kawaguchi, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Manabe, N.
Right arrow Articles by Kawaguchi, H.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 1999; 38: 714-720
© 1999 British Society for Rheumatology

Involvement of fibroblast growth factor-2 in joint destruction of rheumatoid arthritis patients

N. Manabe, H. Oda, K. Nakamura, Y. Kuga1, S. Uchida1 and H. Kawaguchi

Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo and
1 Center of Rheumatic Disease, Tokyo Government Hospital of Bokuto, Tokyo, Japan

Correspondence to: H. Kawaguchi, Department of Orthopaedic Surgery, Faculty of Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo, Tokyo 113-8655, Japan.

Objective. To investigate the effect of the synovial fluid from knee joints of rheumatoid arthritis (RA) patients with different severities of joint destruction on osteoclastogenesis and bone resorption.

Methods. Synovial fluid was harvested from the knee joints of 59 RA patients and 37 osteoarthritis (OA) patients. RA patients with Larsen's knee grade 1–3 were classified as mild RA (n=30) and those with grade 4 or 5 as severe RA (n=29). Cytokine concentrations in synovial fluid were measured by ELISA. Osteoclastogenesis was measured by tartrate-resistant acid phosphatase (TRAP)-positive multinucleated cell (MNC) formation in a co-culture of mouse osteoblastic cells and bone marrow cells, and bone resorption by 45Ca release from pre-labelled cultured neonatal mouse calvariae.

Results. The synovial fluid of severe RA patients significantly stimulated TRAP-positive MNC formation and 45Ca release compared to those of mild RA and OA patients. Among the bone-resorptive cytokines fibroblast growth factor-2 (FGF-2), tumour necrosis factor alpha (TNF-{alpha}), interleukin-1{alpha} (IL-1{alpha}), IL-6 and soluble IL-6 receptor (sIL-6R), only FGF-2 concentration in the synovial fluid was positively correlated to Larsen's grade, and severe RA patients showed significantly higher FGF-2 concentrations than mild RA patients. Osteoclastogenesis in a co-culture system which was stimulated by the synovial fluid of severe RA patients was significantly inhibited by a neutralizing antibody against FGF-2 and this inhibition was stronger than antibodies against other cytokines.

Conclusion. The increase in endogenous FGF-2 levels in the synovial fluid of RA patients may play a role in the joint destruction by inducing osteoclastogenesis.

KEY WORDS: Fibroblast growth factor, Joint destruction, Bone resorption, Synovial fluid, Cytokine, Osteoclast, Rheumatoid arthritis.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
H. Takano, T. Tomita, T. Toyosaki-Maeda, M. Maeda-Tanimura, H. Tsuboi, E. Takeuchi, M. Kaneko, K. Shi, K. Takahi, A. Myoui, et al.
Comparison of the activities of multinucleated bone-resorbing giant cells derived from CD14-positive cells in the synovial fluids of rheumatoid arthritis and osteoarthritis patients
Rheumatology, April 1, 2004; 43(4): 435 - 441.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
T. Shimoaka, T. Ogasawara, A. Yonamine, D. Chikazu, H. Kawano, K. Nakamura, N. Itoh, and H. Kawaguchi
Regulation of Osteoblast, Chondrocyte, and Osteoclast Functions by Fibroblast Growth Factor (FGF)-18 in Comparison with FGF-2 and FGF-10
J. Biol. Chem., February 22, 2002; 277(9): 7493 - 7500.
[Abstract] [Full Text] [PDF]

Home page
 J. Immunol.Home page
A. Yamashita, Y. Yonemitsu, S. Okano, K. Nakagawa, Y. Nakashima, T. Irisa, Y. Iwamoto, Y. Nagai, M. Hasegawa, and K. Sueishi
Fibroblast Growth Factor-2 Determines Severity of Joint Disease in Adjuvant-Induced Arthritis in Rats
J. Immunol., January 1, 2002; 168(1): 450 - 457.
[Abstract] [Full Text] [PDF]

Home page
 Exp. Biol. Med.Home page
B. A. Watkins, Y. Li, H. E. Lippman, and M. F. Seifert
Omega-3 Polyunsaturated Fatty Acids and Skeletal Health
Experimental Biology and Medicine, June 1, 2001; 226(6): 485 - 497.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
M. Katagiri, Y. Hakeda, D. Chikazu, T. Ogasawara, T. Takato, M. Kumegawa, K. Nakamura, and H. Kawaguchi
Mechanism of Stimulation of Osteoclastic Bone Resorption through Gas6/Tyro 3, a Receptor Tyrosine Kinase Signaling, in Mouse Osteoclasts
J. Biol. Chem., March 2, 2001; 276(10): 7376 - 7382.
[Abstract] [Full Text] [PDF]

Home page
 J. Biol. Chem.Home page
D. Chikazu, Y. Hakeda, N. Ogata, K. Nemoto, A. Itabashi, T. Takato, M. Kumegawa, K. Nakamura, and H. Kawaguchi
Fibroblast Growth Factor (FGF)-2 Directly Stimulates Mature Osteoclast Function through Activation of FGF Receptor 1 and p42/p44 MAP Kinase
J. Biol. Chem., September 29, 2000; 275(40): 31444 - 31450.
[Abstract] [Full Text] [PDF]


Disclaimer:
Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.